Seed VC · Germany

Vesalius Biocapital

Active

What they invest in

Vesalius Biocapital invests in companies active in human health through venture capital, playing the role of lead investor in the large majority of financing rounds. The investment strategy is focused on three areas: therapeutics, medical devices and diagnostics.

Who they back

DeepTechHealthtechBiotechSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip

Customer segments

Healthcare companies, Pharmaceutical companies

Geography

Europe

Recent investments

  • Activaero
  • Amakem
  • Apitope

+ 3 more deals. Score your deck to see the full investment history.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Vesalius Biocapital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Vesalius Biocapital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
Germany
Last known deal
Jun 2023
Portfolio last checked
Oct 6, 2026
Website
www.vesaliusbiocapital.com ↗

Other firms investing in DeepTech

See all investors

Is Vesalius Biocapital the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Vesalius Biocapital is one of them, and we'll tell you exactly where they sit in your top 100.